Patients with leukemia, metastatic melanoma, sickle-cell disease and Job's syndrome meet with their doctors one last time. After receiving a variety of treatments, it's time to learn whether or not the experimental procedures were successful and what the future holds for them.
By entering your email address, you agree to our Terms of Use and acknowledge the Privacy Policy. discovery and its affiliates may use your email address to provide updates, ads, and offers.
To withdraw your consent or learn more about your rights, see the Privacy Policy.